Levosimendan versus an Intra-Aortic Balloon Pump in High-Risk Cardiac Patients
To test the hypothesis that levosimendan is more effective than intra-aortic balloon pump (IABP) support in cardiac surgical patients with low left ventricular ejection fraction to decrease cardiac troponin I levels (primary endpoint) and improve hemodynamics.
